The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1275 articles
On The View, Joy Behar, 83, proudly shared losing 25 lbs on a GLP-1 medication, boasting 'We all did it!' alongside Whoopi Goldberg and guest Savannah Chrisley. The co-hosts opened up about their transformative weight loss experiences with drugs like Ozempic and Mounjaro. This candid discussion highlights the growing popularity of GLP-1s among celebrities.
GLP-1 medications like those approved for weight loss can transform your journey, but nutrition plays a key role in maximizing benefits. A pilot clinical trial by Atkins shows that pairing GLP-1s with higher protein and fiber helps maintain healthier body composition. These 4 tips—fiber, protein, hydration, and small meals—can help you feel energized and supported.
Indian drugmaker Dr Reddy's Laboratories is gearing up to launch a generic version of Novo Nordisk's Wegovy at prices up to 60% lower than the original. Co-chairman G V Prasad confirmed 50-60% discounts are feasible as semaglutide's patent nears expiry in March. This could reshape access to weight-loss treatments in India's competitive market.
American Made GLP-1 has crowned CoreAge Rx as the best GLP-1 provider for 2026, earning a stellar 4.9 out of 5 rating after reviewing over 10 U.S. telehealth platforms. The 'Editor's Choice' award highlights its FDA-approved semaglutide and tirzepatide programs with board-certified physician oversight. Patients report 10-26% body weight loss in 12 months with personalized care.
An independent review by GLP-1 Planet has crowned CoreAge Rx as the top GLP-1 provider out of 78 evaluated, with a standout 9.6/10 rating driven by its $99/month flat pricing. This includes virtual consultations, medications like semaglutide and tirzepatide, ongoing support, and direct delivery. Patients benefit from transparent, comprehensive weight management care.
American Girl Dolls have undergone a controversial 'Ozempic' makeover, with slimmer bodies aimed at the 'modern era'—but many parents and influencers are far from impressed. The redesign highlights the cultural impact of GLP-1 medications like Ozempic on body ideals. Explore the debate, drug mechanisms, and health considerations.
Food noise isn't just hunger—it's exhausting mental commentary on dieting, body image, and worthiness shaped by culture. While Ozempic and GLP-1 agonists like Wegovy promise relief, clinicians Bronwyn Wood and Courtney Nelson argue for a broader approach. Their workshops challenge weight-centric care to foster true silencing through body neutrality and informed prescribing.
Hollywood's shift to GLP-1 drugs like Ozempic has led to leaner figures on the red carpet, but some celebs are facing 'Ozempic neck'—loose skin from fast weight loss. This guide explains the phenomenon, its causes, and strategies to manage it. Understand why skin struggles to keep up with GLP-1-induced changes.
GLP-1 receptor agonists, originally developed for diabetes, are gaining attention for potential benefits in multiple sclerosis (MS) due to their effects on the brain and metabolic health. Expert Afsaneh Shirani, MD, highlighted promising studies at ACTRIMS, including weight loss and minimal relapses, but stressed the need for more rigorous trials. Key challenges like biomarkers, patient selection, and access remain.
